Softcare Limited (02698) filed its Monthly Return for Equity Issuer for the period ended 31 May 2026, showing no changes to either authorised or issued share capital.

Authorised share capital • Authorised share count held steady at 1.00 billion ordinary shares with a par value of USD 0.0001, representing an unchanged authorised capital of USD 100,000.

Issued share capital and treasury shares • Issued shares remained at 620.77 million, with no treasury shares outstanding or cancelled during the month. • As no shares were issued, repurchased or cancelled, total issued share capital stayed flat.

Public float compliance • Management confirmed compliance with the Main Board minimum public-float requirement. The company continues to meet the 15 % threshold set at listing.

Share option activity Pre-IPO Scheme (adopted 15 Jan 2025) – Options outstanding: 1.06 million (unchanged month-on-month). – New shares issued from option exercises: none. – Shares still issuable upon full exercise of existing options: 66,507.

Post-IPO Scheme (adopted 27 Oct 2025) – No options outstanding to date. – Authorised pool available for future grants: 60.59 million shares.

Capital raised • No funds were generated from option exercises during May 2026.

Overall, Softcare’s equity structure and authorised capital base remained static through May, with ample headroom in its Post-IPO share option pool and full adherence to Hong Kong Stock Exchange public float rules.